Skip to main content
. 2014 May 22;2014(5):CD002947. doi: 10.1002/14651858.CD002947.pub2

Comparison 31. Chinese BNHS versus glucosamine sulphate.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Pain VAS 0‐100 (walking) 1 60 Mean Difference (IV, Random, 95% CI) ‐2.0 [‐6.81, 2.81]
2 WOMAC‐VAS (Function) 1 60 Mean Difference (IV, Random, 95% CI) 0.0 [‐2.53, 2.53]
3 Participants (n) reported adverse events 1 60 Risk Ratio (M‐H, Random, 95% CI) 9.00 [0.51, 160.17]